• Pacira Biosciences, Inc. v. Fortis Advisors LLC

    Publication Date: 2025-02-04
    Practice Area: Mergers and Acquisitions
    Industry: Health Care | Investments and Investment Advisory | Pharmaceuticals
    Court: Court of Chancery
    Judge: Vice Chancellor Fioravanti
    Attorneys: For plaintiff: Lisa A. Schmidt, Raymond J. DiCamillo, Kevin M. Kidwell, Richards, Layton & Finger, P.A., Wilmington, DE; Anne Champion, Zainab Ahmad, Timothy Sun, Maya Danaher, Gibson, Dunn & Crutcher LLC, New York, NY for plaintiffs.
    for defendant: Lauren K. Neal, Courtney Kurz, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Christopher J. Marino, Taylor P. Lovejoy, Davis Malm & D’Agostine, P.C., Boston, MA for defendant.

    Case Number: 2020-0694-PAF

    Court granted declaratory judgment for plaintiffs where extrinsic evidence demonstrated that the parties intended to use national reimbursement rates and for alternative CPT codes to only apply when used and effective for acquired company's product.